About us

Perfusion Tech
in brief

PerfusionTech is a Copenhagen-based MedTech company established in 2016
Company developes and markets image analysis software for intrasurgical perfusion quantification and visualization
PerfusionWorks software for real-time perfusion quantification in selected areas is available for sales within Europe
PerfusionWorks software for blood vessel mapping is available to the market by 2024

Perfusion Tech in brief

PerfusionTech is a Copenhagen-based MedTech company established in 2016

Company developes and markets image analysis software for intrasurgical perfusion quantification and visualization

PerfusionWorks software for real-time perfusion quantification in selected areas is available for sales within Europe

PerfusionWorks software for blood vessel mapping is available to the market by 2026

Perfusion Tech’s journey

Our story so far

2016
PerfusionTech established Filing of patent #1: “System and method for assessing perfusion in an anatomical structure”.
2018
Filing of patent #2: “System and method for automatic perfusion measurement”
2019
End feasibility study within colorectal cancer surgery

Filing of patent #3: “System and method for identifying blood vessels during fluorescence imaging”
2020
End clinical study within colorectal cancer surgery
 
CE-marking of PerfusionWorks within colorectal cancer surgery
2021
Filing of patent #4: “System and method for identifying an abnormal perfusion pattern”

CE-mark on PerfusionWorks extended to cover a broad range of surgical specialties

Initiation of 150 patients multicenter study “QUANTICO” within colorectal cancer surgery
2022
Filing of patent #5: “System and method for lymph node mapping”

Eurostars Grant obtained with DK/NL syndicate Pre-clinical studies on the use of micro-dosing technology initiated

First software installations at customers

ISO 13485 Stage 1 audit passed
2023
ISO 13485 Certified (BSI)

Partnership with strategic investor and commercialisation partner Renew Health Ltd. initiated
2024
Last patient included in "QUANTICO" multicenter study within colorectal cancer surgery

Submission for CE-marking under MDR
OUR STORY SO FAR

Perfusion Tech’s journey
‍

2022:
Filing of patent #5: “System and method for lymph node mapping”
Eurostars Grant obtained with DK/NL syndicate
Pre-clinical studies on the use of micro-dosing technology initiated
First software installations at customers
ISO 13485 Stage 1 audit passed

Customer Name

Company Name

2021:
Filing of patent #4: “System and method for identifying an abnormal perfusion pattern”
CE-mark on PerfusionWorks extended to cover a broad range of surgical specialties
initiation of 250 pts multicenter study “QUANTICO” within colorectal cancer surgery

Customer Name

Company Name

2020:
End clinical study within colorectal cancer surgery
CE-marking of PerfusionWorks within colorectal cancer surgery

Customer Name

Company Name

2019:
End feasibility study withincolorectal cancer surgery
Filing of patent #3: “Systemand method for identifying blood vessels during fluorescence imaging”

Customer Name

Company Name

2018:
Filing of patent #2: “Systemand method for automatic perfusion measurement”

Customer Name

Company Name

2016:
PerfusionTech established
Filing of patent #1: “Systemand method for assessing perfusion in an anatomical structure”.

Customer Name

Company Name
Meet our

Management team

The management team coordinates between our medical team, software team, and the board.
Pernille Singer
CEO
Co-owner of Perfusion Tech 20+ years MedTech leadership experience from larger international MedTech companies
Mads H. A. Madsen, PhD
CTO
Founder & co-owner of Perfusion Tech
PhD in physics, expert knowledge in advanced image analysis and fluorescence technology
Morten A. V. Lund, MD
CSO
Founder & co-owner of Perfusion Tech
Global Clinical Research Programme, Harvard (hons) Clinical research and study design experience.
Ronald Borra, MD, PhD
CMO
Senior Consultant, Professor of Experimental Radiology & Nuclear Medicine & Molecular Imaging at University of Turku (FI) & Groningen (NL)
Tommy Poulsen
VP Software Development
20+ years experience with MedTech software development.
Experienced people leader.
Brian Heedegaard
QA/RA Manager (interim)
Medical device software specialist with 25+ years of experience within software development and 14 years with digital health, digitalization of medical devices and Software as Medical Device (SaMD/MDSW).
Certified ISO 13485 auditor
Meet our

Scientific Advisory Board

Ismail Gögenur, MD, DMSc
Clinical Advisor
Professor and consultant Department of Surgery, Zealand University Hospital.. Head of Center for Surgical Science, Region Zealand.
Thomas Jonassen, MD
Clinical Advisor
Co-owner of Perfusion Tech Associate Professor, Univ Cph 15+ years in Biotech- Co-founder of 4 Biotech Companies
Michael Hasenkam, MD, DMSc
Clinical Advisor
Professor at Department of Clinical Medicine & Department of Thoracic and Cardiovascular Surgery at Aarhus University
Meet our

Board of Directors

Henrik Christensen - Chair
‍
CEO Kementec Solutions A/S 20+ years in biotech/MedTech companies 
Mads H. A. Madsen
‍
PhD; CTO Perfusion Tech
Thomas Jonassen
‍
MD; 15+ years in Biotech-Cofounder of 4 Biotech Companies
Sten Scheibye
‍
Extensive CEO- and Board experience. From the Life Science Industry
Jeppe Øvli Øvlesen
‍
MBA; CEO SynAct Pharma Founding Board Member / Co- founder of more than 15 biotech / MedTech companies
Declan Cassells
‍
Managing Director,
Renew Health Ltd.
20 years’ experience in the medical device industry

PerfusionTech’s
patent portfolio

U.S.Pat. 10,271,750

#1

“System and method for assessing perfusion in an anatomical structure”.

PerfusionWorks 1.0 algoritm

Priority:
Dec 2016

US: Granted
CN: Granted
EU: Pending

PCT/EP2019/065648, USPTO 16/738,078

#2

“System and method for automatic perfusion measurement”

Automated perfusion surveillance and microdosing

Priority:
Jun 2018

US: Granted
EU: Pending

EP 21181561.8

#4

“System and method for identifying an abnormal perfusion pattern”

Detection of abnormal tissue

Priority:
Jun 2021

US & EU:
Pending

EP 22183831.1

#5

“System and method for lymph node mapping”

Lymph-node detection

Priority:
Jun 2022

US & EU:
Pending

why choose north?

"PerfusionTech has been a life saver from day one. We now have clear overview of all our activities"

Esther Howard

Founder, Truely

Want to get in touch?